{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:15:33Z","timestamp":1762956933977,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Aga Khan Development Network","award":["330842553"],"award-info":[{"award-number":["330842553"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11033-022-07831-1","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T18:03:40Z","timestamp":1663005820000},"page":"10347-10356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic modulation of anemia severity, hemolysis level, and hospitalization rate in Angolan children with Sickle Cell Anemia"],"prefix":"10.1007","volume":"49","author":[{"given":"Isabel","family":"Germano","sequence":"first","affiliation":[]},{"given":"Br\u00edgida","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Delgadinho","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Ginete","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Arez","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Brito","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6269-4867","authenticated-orcid":false,"given":"Paula","family":"Faustino","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"7831_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC (2017) Sickle Cell Disease. N Engl J Med 376:1561\u20131573. https:\/\/doi.org\/10.1056\/NEJMra1510865","journal-title":"N Engl J Med"},{"key":"7831_CR2","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD et al (2018) Sickle cell disease. Nat Rev Dis Prim 4:18010. https:\/\/doi.org\/10.1038\/nrdp.2018.10","journal-title":"Nat Rev Dis Prim"},{"key":"7831_CR3","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","volume":"41","author":"SD Grosse","year":"2011","unstructured":"Grosse SD, Odame I, Atrash HK et al (2011) Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med 41:S398\u2013405. https:\/\/doi.org\/10.1016\/j.amepre.2011.09.013","journal-title":"Am J Prev Med"},{"key":"7831_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.hoc.2015.11.005","volume":"30","author":"TN Williams","year":"2016","unstructured":"Williams TN (2016) Sickle Cell Disease in Sub-Saharan Africa. Hematol Oncol Clin North Am 30:343\u2013358. https:\/\/doi.org\/10.1016\/j.hoc.2015.11.005","journal-title":"Hematol Oncol Clin North Am"},{"key":"7831_CR5","doi-asserted-by":"crossref","unstructured":"Andrade V, Arango M, Abreu S, Flores I(2014) One Company\u2019s Angola Sickle Cell Program. SPE Int. Conf. Heal. Safety, Environ. D031S054R004","DOI":"10.2118\/168531-MS"},{"key":"7831_CR6","doi-asserted-by":"publisher","first-page":"a011783","DOI":"10.1101\/cshperspect.a011783","volume":"3","author":"GR Serjeant","year":"2013","unstructured":"Serjeant GR (2013) The natural history of sickle cell disease. Cold Spring Harb Perspect Med 3:a011783. https:\/\/doi.org\/10.1101\/cshperspect.a011783","journal-title":"Cold Spring Harb Perspect Med"},{"key":"7831_CR7","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1007\/s11033-020-05628-8","volume":"47","author":"B Santos","year":"2020","unstructured":"Santos B, Delgadinho M, Ferreira J et al (2020) Co-Inheritance of alpha-thalassemia and sickle cell disease in a cohort of Angolan pediatric patients. Mol Biol Rep 47:5397\u20135402. https:\/\/doi.org\/10.1007\/s11033-020-05628-8","journal-title":"Mol Biol Rep"},{"key":"7831_CR8","first-page":"364","volume":"62","author":"JB Schnog","year":"2004","unstructured":"Schnog JB, Duits AJ, Muskiet FAJ et al (2004) Sickle cell disease; a general overview. Neth J Med 62:364\u2013374","journal-title":"Neth J Med"},{"key":"7831_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","volume":"21","author":"GJ Kato","year":"2007","unstructured":"Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21:37\u201347. https:\/\/doi.org\/10.1016\/j.blre.2006.07.001","journal-title":"Blood Rev"},{"key":"7831_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.gene.2015.09.061","volume":"575","author":"GH Oliveira-Paula","year":"2016","unstructured":"Oliveira-Paula GH, Lacchini R, Tanus-Santos JE (2016) Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms. Gene 575:584\u2013599. https:\/\/doi.org\/10.1016\/j.gene.2015.09.061","journal-title":"Gene"},{"key":"7831_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1182\/blood.V85.1.268.bloodjournal851268","volume":"85","author":"BE Gee","year":"1995","unstructured":"Gee BE, Platt OS (1995) Sickle reticulocytes adhere to VCAM-1. Blood 85:268\u2013274","journal-title":"Blood"},{"key":"7831_CR12","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.bcmd.2019.102397","volume":"81","author":"J White","year":"2020","unstructured":"White J, Lancelot M, Gao X et al (2020) Cross-sectional analysis of adhesion in individuals with sickle cell disease using a standardized whole blood adhesion bioassay to VCAM-1. Blood Cells Mol Dis 81:102397. https:\/\/doi.org\/10.1016\/j.bcmd.2019.102397","journal-title":"Blood Cells Mol Dis"},{"key":"7831_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.21928","volume":"86","author":"DA Dworkis","year":"2011","unstructured":"Dworkis DA, Klings ES, Solovieff N et al (2011) Severe sickle cell anemia is associated with increased plasma levels of TNF-R1 and VCAM-1. Am J Hematol 86:220","journal-title":"Am J Hematol"},{"key":"7831_CR14","doi-asserted-by":"publisher","unstructured":"Wautier J-L, Wautier M-P (2020) Cellular and Molecular Aspects of Blood Cell-Endothelium Interactions in Vascular Disorders. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21155315","DOI":"10.3390\/ijms21155315"},{"key":"7831_CR15","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2003-09-3015","volume":"103","author":"C Hoppe","year":"2004","unstructured":"Hoppe C, Klitz W, Cheng S et al (2004) Gene interactions and stroke risk in children with sickle cell anemia. Blood 103:2391\u20132396. https:\/\/doi.org\/10.1182\/blood-2003-09-3015","journal-title":"Blood"},{"key":"7831_CR16","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1182\/blood-2001-12-0306","volume":"100","author":"JG Taylor 6th","year":"2002","unstructured":"Taylor JG 6th, Tang DC, Savage SA et al (2002) Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100:4303\u20134309. https:\/\/doi.org\/10.1182\/blood-2001-12-0306","journal-title":"Blood"},{"key":"7831_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/humu.20523","volume":"28","author":"G Idelman","year":"2007","unstructured":"Idelman G, Taylor JG, Tongbai R et al (2007) Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations. Hum Mutat 28:824\u2013829. https:\/\/doi.org\/10.1002\/humu.20523","journal-title":"Hum Mutat"},{"key":"7831_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ejh.12226","volume":"92","author":"A Coelho","year":"2014","unstructured":"Coelho A, Dias A, Morais A et al (2014) Genetic variation in CD36, HBA, NOS3 and VCAM1 is associated with chronic haemolysis level in sickle cell anaemia: A longitudinal study. Eur J Haematol 92:237\u2013243. https:\/\/doi.org\/10.1111\/ejh.12226","journal-title":"Eur J Haematol"},{"key":"7831_CR19","doi-asserted-by":"publisher","first-page":"102436","DOI":"10.1016\/j.bcmd.2020.102436","volume":"83","author":"M Silva","year":"2020","unstructured":"Silva M, Vargas S, Coelho A et al (2020) Biomarkers and genetic modulators of cerebral vasculopathy in sub-Saharan ancestry children with sickle cell anemia. Blood Cells Mol Dis 83:102436","journal-title":"Blood Cells Mol Dis"},{"key":"7831_CR20","doi-asserted-by":"publisher","unstructured":"Silva M, Coelho A, Vargas S, Faustino P (2022) VCAM1, HMOX1 and NOS3 differential endothelial expression may impact sickle cell anemia vasculopathy. Blood cells, Mol & Dis 93:102639. https:\/\/doi.org\/10.1016\/j.bcmd.2021.102639","DOI":"10.1016\/j.bcmd.2021.102639"},{"key":"7831_CR21","doi-asserted-by":"publisher","first-page":"100637","DOI":"10.1016\/j.blre.2019.100637","volume":"40","author":"MA Carden","year":"2020","unstructured":"Carden MA, Fasano RM, Meier ER (2020) Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia. Blood Rev 40:100637. https:\/\/doi.org\/10.1016\/j.blre.2019.100637","journal-title":"Blood Rev"},{"key":"7831_CR22","doi-asserted-by":"publisher","first-page":"155534","DOI":"10.1016\/j.cyto.2021.155534","volume":"143","author":"HK Abdul-Hussein","year":"2021","unstructured":"Abdul-Hussein HK, Al-Mammori HS, Hassan MK (2021) Evaluation of the expression of red blood cell CD36, interleukin-6 and interleukin-8 in sickle cell anemia pediatric patients. Cytokine 143:155534. https:\/\/doi.org\/10.1016\/j.cyto.2021.155534","journal-title":"Cytokine"},{"key":"7831_CR23","unstructured":"WHO (2011) Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/85839\/WHO_NMH_NHD_MNM_11.1_eng.pdf. Accessed 14 Jan 2022"},{"key":"7831_CR24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978\u2013989","journal-title":"Am J Hum Genet"},{"key":"7831_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1086\/428594","volume":"76","author":"M Stephens","year":"2005","unstructured":"Stephens M, Scheet P (2005) Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 76:449\u2013462","journal-title":"Am J Hum Genet"},{"key":"7831_CR26","doi-asserted-by":"publisher","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","volume":"49","author":"KL Howe","year":"2021","unstructured":"Howe KL, Achuthan P, Allen J et al (2021) Ensembl 2021. Nucleic Acids Res 49:D884\u2013D891. https:\/\/doi.org\/10.1093\/nar\/gkaa942","journal-title":"Nucleic Acids Res"},{"key":"7831_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1046\/j.1365-2141.2003.04762.x","volume":"124","author":"K Sharan","year":"2004","unstructured":"Sharan K, Surrey S, Ballas S et al (2004) Association of T-786\u00a0C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Haematol 124:240\u2013243. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04762.x","journal-title":"Br J Haematol"},{"key":"7831_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1399-0039.2005.00506.x","volume":"66","author":"AE Vargas","year":"2005","unstructured":"Vargas AE, da Silva MAL, Silla L, Chies JAB (2005) Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease. Tissue Antigens 66:683\u2013690. https:\/\/doi.org\/10.1111\/j.1399-0039.2005.00506.x","journal-title":"Tissue Antigens"},{"key":"7831_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10245332.2016.1142710","volume":"21","author":"SM Yousry","year":"2016","unstructured":"Yousry SM, Ellithy HN, Shahin GH (2016) Endothelial nitric oxide synthase gene polymorphisms and the risk of vasculopathy in sickle cell disease. Hematology 21:359\u2013367. https:\/\/doi.org\/10.1080\/10245332.2016.1142710","journal-title":"Hematology"},{"key":"7831_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.niox.2016.11.002","volume":"62","author":"I Armenis","year":"2017","unstructured":"Armenis I, Kalotychou V, Tzanetea R et al (2017) Prognostic value of T786C and G894T eNOS polymorphisms in sickle cell disease. Nitric Oxide 62:17\u201323. https:\/\/doi.org\/10.1016\/j.niox.2016.11.002","journal-title":"Nitric Oxide"},{"key":"7831_CR31","doi-asserted-by":"publisher","unstructured":"Antwi-Boasiako C, Dzudzor B, Kudzi W et al(2018) Association between eNOS Gene Polymorphism (T786C and VNTR) and Sickle Cell Disease Patients in Ghana. Dis (Basel, Switzerland) 6:. https:\/\/doi.org\/10.3390\/diseases6040090","DOI":"10.3390\/diseases6040090"},{"key":"7831_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/jhg.2013.99","volume":"58","author":"SS Nishank","year":"2013","unstructured":"Nishank SS, Singh MPSS, Yadav R et al (2013) Endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease patients in India. J Hum Genet 58:775\u2013779. https:\/\/doi.org\/10.1038\/jhg.2013.99","journal-title":"J Hum Genet"},{"key":"7831_CR33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/00008571-200111000-00011","volume":"11","author":"JE Tanus-Santos","year":"2001","unstructured":"Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11:719\u2013725. https:\/\/doi.org\/10.1097\/00008571-200111000-00011","journal-title":"Pharmacogenetics"},{"key":"7831_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12881-017-0491-7","volume":"18","author":"S Gamil","year":"2017","unstructured":"Gamil S, Erdmann J, Abdalrahman IB, Mohamed AO (2017) Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study. BMC Med Genet 18:128. https:\/\/doi.org\/10.1186\/s12881-017-0491-7","journal-title":"BMC Med Genet"},{"key":"7831_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s43141-021-00260-w","volume":"19","author":"A Elsaid","year":"2021","unstructured":"Elsaid A, Samir Eid O, Said SB, Zahran RF (2021) Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients. J Genet Eng Biotechnol 19:158. https:\/\/doi.org\/10.1186\/s43141-021-00260-w","journal-title":"J Genet Eng Biotechnol"},{"key":"7831_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/10245332.2016.1253253","volume":"22","author":"M Kalai","year":"2017","unstructured":"Kalai M, Dridi M, Chaouch L et al (2017) The role of rs1984112_G at CD36 gene in increasing reticulocyte level among sickle cell disease patients. Hematology 22:178\u2013182. https:\/\/doi.org\/10.1080\/10245332.2016.1253253","journal-title":"Hematology"},{"key":"7831_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cca.2012.11.028","volume":"417","author":"AC Rodrigues","year":"2013","unstructured":"Rodrigues AC, Sobrino B, Genvigir FDV et al (2013) Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clin Chim Acta 417:8\u201311. https:\/\/doi.org\/10.1016\/j.cca.2012.11.028","journal-title":"Clin Chim Acta"},{"key":"7831_CR38","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3945\/ajcn.110.004176","volume":"93","author":"S Lecompte","year":"2011","unstructured":"Lecompte S, Szabo de Edelenyi F, Goumidi L et al (2011) Polymorphisms in the CD36\/FAT gene are associated with plasma vitamin E concentrations in humans1\u20133. Am J Clin Nutr 93:644\u2013651. https:\/\/doi.org\/10.3945\/ajcn.110.004176","journal-title":"Am J Clin Nutr"},{"key":"7831_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1242\/jcs.181008","volume":"129","author":"T Kurosaki","year":"2016","unstructured":"Kurosaki T, Maquat LE (2016) Nonsense-mediated mRNA decay in humans at a glance. J Cell Sci 129:461\u2013467. https:\/\/doi.org\/10.1242\/jcs.181008","journal-title":"J Cell Sci"},{"key":"7831_CR40","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/hmg\/ddp192","volume":"18","author":"AE Fry","year":"2009","unstructured":"Fry AE, Ghansa A, Small KS et al (2009) Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet 18:2683\u20132692. https:\/\/doi.org\/10.1093\/hmg\/ddp192","journal-title":"Hum Mol Genet"},{"key":"7831_CR41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/35016636","volume":"405","author":"TJ Aitman","year":"2000","unstructured":"Aitman TJ, Cooper LD, Norsworthy PJ et al (2000) Malaria susceptibility and CD36 mutation. Nature 405:1015\u20131016. https:\/\/doi.org\/10.1038\/35016636","journal-title":"Nature"},{"key":"7831_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.pt.2014.07.006","volume":"30","author":"A Cabrera","year":"2014","unstructured":"Cabrera A, Neculai D, Kain KC (2014) CD36 and malaria: friends or foes? A decade of data provides some answers. Trends Parasitol 30:436\u2013444. https:\/\/doi.org\/10.1016\/j.pt.2014.07.006","journal-title":"Trends Parasitol"},{"key":"7831_CR43","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1182\/blood.v98.4.966","volume":"98","author":"K Lee","year":"2001","unstructured":"Lee K, Gane P, Roudot-Thoraval F et al (2001) The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia. Blood 98:966\u2013971. https:\/\/doi.org\/10.1182\/blood.v98.4.966","journal-title":"Blood"},{"key":"7831_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tracli.2008.05.001","volume":"15","author":"J-P Cartron","year":"2008","unstructured":"Cartron J-P, Elion J (2008) Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfus Clin Biol J la Soc Fr Transfus Sang 15:39\u201350. https:\/\/doi.org\/10.1016\/j.tracli.2008.05.001","journal-title":"Transfus Clin Biol J la Soc Fr Transfus Sang"},{"key":"7831_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12288-013-0261-4","volume":"30","author":"RK Agrawal","year":"2014","unstructured":"Agrawal RK, Patel RK, Shah V et al (2014) Hydroxyurea in sickle cell disease: drug review. Indian J Hematol blood Transfus an Off J Indian Soc Hematol Blood Transfus 30:91\u201396. https:\/\/doi.org\/10.1007\/s12288-013-0261-4","journal-title":"Indian J Hematol blood Transfus an Off J Indian Soc Hematol Blood Transfus"},{"key":"7831_CR46","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","volume":"14","author":"PT McGann","year":"2015","unstructured":"McGann PT, Ware RE (2015) Hydroxyurea therapy for sickle cell anemia. Expert Opin Drug Saf 14:1749\u20131758. https:\/\/doi.org\/10.1517\/14740338.2015.1088827","journal-title":"Expert Opin Drug Saf"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07831-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T11:04:13Z","timestamp":1667127853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07831-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7831"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07831-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethical Committee of Ministry of Health of Angola (CE. N\u00ba 040\/2018), the Ethical committee of ESTeSL (CE-ESTeSL-N\u00ba.43-2018), INSA and IHMT. This study was performed in line with the principles of the Declaration of Helsinki of 1975, as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The aims and study procedures were explained to the children\u2019s parents or legal guardians, and they provided informed written consent to their enrolment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}